Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
Although high doses of single bioactive agents may have potent anticancer effects, the chemopreventive properties of the Asian diet may result from interactions among several components that potentiate the activities of any single constituent. In Asia, where intake of soy products and tea consumption are very high, aggressive prostate cancer is significantly less prevalent in Asian men. The objective of the present study was to identify possible synergistic effects between soy and tea components on prostate tumor progression in a mouse model of orthotopic androgen-sensitive human prostate cancer. Soy phytochemical concentrate (SPC), black tea and green tea were compared with respect to tumorigenicity rate, primary tumor growth, tumor proliferation index and microvessel density, serum androgen level and metastases to lymph nodes. SPC, black tea and green tea significantly reduced tumorigenicity. SPC and black tea also significantly reduced final tumor weights. Green tea did not reduce final tumor weight, although it tended to elevate (P = 0.14) the serum dihydrotestosterone (DHT) concentration. The combination of SPC and black tea synergistically inhibited prostate tumorigenicity, final tumor weight and metastases to lymph nodes in vivo. The combination of SPC and green tea synergistically inhibited final tumor weight and metastasis and significantly reduced serum concentrations of both testosterone and DHT in vivo. Inhibition of tumor progression was associated with reduced tumor cell proliferation and tumor angiogenesis. This study suggests that further research is warranted to study the role of soy and tea combination as effective nutritional regimens in prostate cancer prevention.
Zhou
Jin-Rong
JR
Nutrition/Metabolism Laboratory, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. jrzhou@caregroup.harvard.edu
Yu
Lunyin
L
Zhong
Ying
Y
Blackburn
George L
GL
D000728:Androgens / Q000097:blood; D000818:Animals; D002392:Catechin / Q000009:adverse effects / Q000627:therapeutic use*; D004032:Diet; D004357:Drug Synergism; D006801:Humans; D008297:Male; D051379:Mice; D016513:Mice, SCID; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D030262:Soybean Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D013662:Tea; D013739:Testosterone / Q000097:blood
D000728:Androgens; D030262:Soybean Proteins; D013662:Tea; D013739:Testosterone; D002392:Catechin